Lluís Puig

Lluís Puig

Auto-generated profile, based on publicly available information

Lluís Puig

Banc de Sang i Teixits de Catalunya (Blood and Tissue Bank of Catalonia, BST), Transfusion Safety Laboratory, 08005 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2017 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
CCC.S. Cohn
C.S. Cohn
LDL.J. Dumont
L.J. Dumont
MLM. Lozano
M. Lozano
DMD.C. Marks
D.C. Marks
LJLacey Johnson
Lacey Johnson
MOM. O'NEill
M. O'NEill

20 April 2012 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
RPR. N. I. Pietersz
R. N. I. Pietersz
HRH. W. Reesink
H. W. Reesink
SPS. Panzer
S. Panzer
MGM. P. Gilbertson
M. P. Gilbertson
MBM. E. Borosak
M. E. Borosak
ESE. Snyder
E. Snyder

6 September 2022 in Viruses
Verified
Journal Article
Open access
PDF file
MPMaria Piron
Maria Piron
Fernando SalvadorFernando Salvador
Fernando Salvador
ECEstrella Caballero
Estrella Caballero
AMAdrian-Sanchez Montalva
Adrian-Sanchez Montalva
MBMarta Bes
Marta Bes
SSSILVIA SAULEDA
SILVIA SAULEDA
Human T-cell lymphotropic virus type 1 and 2 (HTLV-1/2) screening is not mandatory in Spanish blood banks. In Catalonia, selective screening was introduced in 2008, followed by universal screening in 2011. We present herein a 10-year experience of HTLV testing in blood donors. HTLV-1/2 selective screening was performed using Ortho-Clinical Diagnostics HTLV-I/HTLV-II Ab-Capture ELISA between February 2008 and May 2009, then Abbott Prism HTLV-I/ HTLV-II assay until December 2010. Abbott Architect rHTLV-I/II assay was then used for HTLV-1/2 universal screening in pooled samples. INNO-LIA HTLV I/II Score (Fujirebio) and in-house HTLV-1/2 proviral DNA real-time PCR were used in reactive samples. Follow-up was offered to confirm HTLV-1/2 donors in Vall d’Hebron Hospital. Between 2008 and 2017, 51 blood donors were confirmed HTLV positive (46 HTLV-1, 4 HTLV-2 and 1 HTLV) out of 2,114,891 blood donations (1 in 41,468). Sixty-nine percent were female, median age was 40 years and most were born in Latin America (69%), followed by Europe (25%), Africa (4%) and Asia (2%). Screening of relatives and partners identified 12 additional HTLV-1 cases. Lookback studies did not show any HTLV-1/2 transmission. HTLV infections found in blood donors mirror epidemiological changes in the population of Spain. Consequently, HTLV should be considered a potential risk for recipients and calls for the design of optimal strategies to ensure transfusion safety.

1 February 2020 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
LRLl. Puig Rovira
Ll. Puig Rovira